Clinical Trial D9289C00008

Trial

Alexion – ALXN1210-PNH-323 (D9289C00008)

Clinical trial ID

D9289C00008

Drug name

ALXN1210

Company:

Alexion Pharmaceuticals, Inc.

Drug trade name

Ravulizumab

Clinicaltrials.gov

Learn more

Phase of study

3

Current status

Active, not recruiting

Start

2024-10-10

Substance

Research question

Delivery method of drug

Intravenous (IV) infusion

Frequency

Clinical trial locations

China